Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy
Open Access
- 16 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (5), 604-611
- https://doi.org/10.1093/cid/ciq188
Abstract
Background. We describe a heart transplant patient with painful periostitis and exostoses who was receiving long-term therapy with voriconazole, which is a fluoride-containing medication. Elevated plasma and bone fluoride levels were identified. Discontinuation of voriconazole therapy led to improvement in pain and reduced fluoride and alkaline phosphatase levels. Methods. To determine whether voriconazole is a cause of fluoride excess, we measured plasma fluoride levels in 10 adult post-transplant patients who had received voriconazole for at least 6 months and 10 post-transplant patients who did not receive voriconazole. To assess the effect of renal insufficiency on fluoride levels in subjects receiving voriconazole, half were recruited on the basis of a serum creatinine level of ≥1.4 mg/dL on their most recent measurement, whereas the other 5 subjects receiving voriconazole had serum creatinine levels Results. All subjects who received voriconazole had elevated plasma fluoride levels, and no subjects in the control group had elevated levels (14.32 μmol/L ± 6.41 vs 2.54 ± 0.67 μmol/L; P<.001). Renal function was not predictive of fluoride levels. Plasma fluoride levels remained significantly higher in the voriconazole group after adjusting for calcineurin inhibitor levels and doses. Half of the voriconazole group subjects had evidence of periostitis, including exostoses in 2 patients. Discontinuation of voriconazole therapy in patients with periostitis resulted in improvement of pain and a reduction in alkaline phosphatase and fluoride levels. Conclusions. Voriconazole is associated with painful periostitis, exostoses, and fluoride excess in post-transplant patients with long-term voriconazole use.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotypeBritish Journal of Clinical Pharmacology, 2009
- Periostitis Secondary to Prolonged Voriconazole Therapy in Lung Transplant RecipientsAmerican Journal of Transplantation, 2009
- Skeletal Fluorosis From Instant TeaJournal of Bone and Mineral Research, 2008
- Important fluorinated drugs in experimental and clinical useJournal of Fluorine Chemistry, 2002
- The Relationship Between Cytochrome P4502E1 Activity and Plasma Fluoride Levels After Sevoflurane Anesthesia in HumansAnesthesia & Analgesia, 1997
- Plasma Inorganic Fluoride Concentrations after Sevoflurane Anesthesia in ChildrenAnesthesiology, 1996
- Outline of control practice of endemic fluorosis in ChinaSocial Science & Medicine (1982), 1995
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- 24- and 26-Homo-1, 25-dihydroxyvitamin D3 Analogs: Potencies on in vitro bone resorption differ from those reported for cell differentiationJournal of Bone and Mineral Research, 1990
- Characterization of the latent transforming growth factor ß complex in BoneJournal of Bone and Mineral Research, 1990